Related Experiment Video
Updated: Apr 4, 2026
07:35
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
Published on: April 21, 2022
2.8K
Update on Pharmacologic Retinal Vascular Toxicity.
Stephen G Schwartz1, Andrzej Grzybowski, Weronika Wasinska-Borowiec
1Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL, 34103, USA. sschwartz2@med.miami.edu.
Current Pharmaceutical Design
|September 10, 2015
Summary
Medications can cause retinal vascular toxicity, affecting vision. Early diagnosis of drug-induced retinal conditions, like talc emboli, is crucial for preventing irreversible vision loss.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Medications are known to cause various forms of retinal vascular toxicity.
- This toxicity represents a clinically significant, though relatively small, category of adverse drug events.
Purpose of the Study:
- To review medications associated with retinal vascular toxicity.
- To highlight diagnostic features and clinical relevance of drug-induced retinal vascular damage.
Main Methods:
- Literature review of medications linked to retinal vascular toxicity.
- Analysis of clinical manifestations and diagnostic challenges.
Main Results:
- Identified agents include intraocular aminoglycosides, oral contraceptives, interferon alpha, and talc (as an intravenous abuse vehicle).
- Manifestations range from nonspecific retinal vascular occlusion to specific findings like talc emboli.
- Toxicity can lead to asymptomatic findings or irreversible visual loss.
Conclusions:
- A high index of suspicion is necessary for diagnosing medication-induced retinal vascular toxicity.
- Prompt diagnosis can aid in management and potentially prevent severe visual impairment.
